- Home
- WMPN vs ASRT Comparison
WMPN vs ASRT Comparison
Compare WMPN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMPN
- ASRT
- Stock Information
- Founded
- WMPN 1870
- ASRT 1995
- Country
- WMPN United States
- ASRT United States
- Employees
- WMPN N/A
- ASRT N/A
- Industry
- WMPN Savings Institutions
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- WMPN Finance
- ASRT Health Care
- Exchange
- WMPN Nasdaq
- ASRT Nasdaq
- Market Cap
- WMPN 112.6M
- ASRT 105.8M
- IPO Year
- WMPN N/A
- ASRT 1997
- Fundamental
- Price
- WMPN $13.02
- ASRT $0.97
- Analyst Decision
- WMPN Buy
- ASRT Strong Buy
- Analyst Count
- WMPN 1
- ASRT 4
- Target Price
- WMPN $14.00
- ASRT $3.19
- AVG Volume (30 Days)
- WMPN 89.0K
- ASRT 909.6K
- Earning Date
- WMPN 10-16-2024
- ASRT 11-11-2024
- Dividend Yield
- WMPN 0.92%
- ASRT N/A
- EPS Growth
- WMPN N/A
- ASRT N/A
- EPS
- WMPN N/A
- ASRT N/A
- Revenue
- WMPN $20,360,000.00
- ASRT $125,763,000.00
- Revenue This Year
- WMPN N/A
- ASRT N/A
- Revenue Next Year
- WMPN N/A
- ASRT $4.68
- P/E Ratio
- WMPN N/A
- ASRT N/A
- Revenue Growth
- WMPN N/A
- ASRT N/A
- 52 Week Low
- WMPN $10.80
- ASRT $0.73
- 52 Week High
- WMPN $13.45
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- WMPN 56.24
- ASRT 48.07
- Support Level
- WMPN $12.83
- ASRT $0.78
- Resistance Level
- WMPN $13.45
- ASRT $1.08
- Average True Range (ATR)
- WMPN 0.28
- ASRT 0.09
- MACD
- WMPN -0.02
- ASRT 0.01
- Stochastic Oscillator
- WMPN 63.57
- ASRT 61.90
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.